Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes

2023

Pennisi, Grazia, Enea, Marco, Falco, Vincenzo, Aithal, Guruprasad, Palaniyappan, Naaventhan, Yilmaz, Yusu, Boursier, Jerome, Cassinotto, Christophe, de Lédinghen, Victor, Chan, Wah Kheong, Mahadeva, Sanjiv, Eddowes, Peter, Newsome, Philip, Karlas, Thomas, Wiegand, Johannes, Wong, Vincent Wai-Sun, Schattenberg, Jörn, Labenz, Christian, Kim, Lee, Myoung Seok, Lupsor-Platon, Monica, Cobbold, Jeremy F., Fan, Jian-Gao18, Shen, Feng, Staufer, Katharina, Trauner, Michael, Stauber, Rudolf, Nakajima, Atsushi, Yoneda, Masato, Bugianesi, Elisabetta, Younes, Ramy, Gaia, Silvia, Zheng, Ming-Hua, Cammà, Calogero, Anstee, Quentin, Mózes, Ferenc, Pavlides, Michael, Petta Salvatore

Apoptotic cell death in disease—Current understanding of the NCCD 2023

2023

Ilio Vitale, Federico Pietrocola, Emma Guilbaud, Stuart A. Aaronson, John M. Abrams, Dieter Adam, Massimiliano Agostini, Patrizia Agostinis, Emad S. Alnemri, Lucia Altucci, Ivano Amelio, David W. Andrews, Rami I. Aqeilan, Eli Arama, Eric H. Baehrecke, Siddharth Balachandran, Daniele Bano, Nickolai A. Barlev, Jiri Bartek, Nicolas G. Bazan, Christoph Becker, Francesca Bernassola, Mathieu J. M. Bertrand, Marco E. Bianchi, …Lorenzo Galluzzi